Researchers used a bioinformatics-plus-rat-model approach to investigate how palmatine may help treat T2DM-associated MASLD, identifying five core targets: ADRB2, BCL3, EGR1, FOS, and MAP3K8. In rats, ...

Atrial fibrillation (AFib) is the most common cardiac arrhythmia worldwide and a major contributor to heart failure (HF), ...

A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...

Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, store energy and process nutrients. If too much fat stays in the liver, it ...

Naturally occurring chemicals found in cannabis have been shown to reduce the risk of potentially deadly fatty liver disease, according to new research. The compounds can “significantly” cut liver fat ...

Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. MASH is the updated term for ...

Cannabis compounds reduces the threat of potentially deadly fatty liver disease, according to new research. Naturally occurring chemicals found in the drug can "significantly" cut liver fat and ...

Fatty liver disease is no longer a niche hepatology problem but is increasingly recognized as a systemic metabolic–inflammatory disorder. Large-scale epidemiological analyses have estimated that ...